financetom
Business
financetom
/
Business
/
Civista Bancshares Files $200 Million Mixed Securities Shelf
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Civista Bancshares Files $200 Million Mixed Securities Shelf
Oct 10, 2024 10:22 PM

01:49 PM EDT, 10/09/2024 (MT Newswires) -- Civista Bancshares ( CIVB ) filed a shelf registration statement with the US Securities and Exchange Commission Wednesday covering the potential sale of up to $200 million of securities from time to time in one or more offerings.

The statement covers common shares, preferred shares, depositary shares, senior debt securities, subordinated debt securities, warrants, subscription rights, purchase contracts, and units.

The company said it will use the net proceeds from any sale of the securities for general corporate purposes, including debt repayment, acquisitions, investments, working capital, and capital expenditures.

Price: 17.42, Change: +0.10, Percent Change: +0.58

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
BMO on The Day Ahead in Canada
BMO on The Day Ahead in Canada
Oct 2, 2024
07:35 AM EDT, 09/27/2024 (MT Newswires) -- Canada's gross domestic product data for July and flash August at 8:30 a.m. ET Friday could have a major bearing on the size of the next rate cut by the country's central bank, said Bank of Montreal (BMO). Real GDP numbers for July and flash August will guide estimates for the quarter, noted...
Top Premarket Decliners
Top Premarket Decliners
Oct 2, 2024
07:42 AM EDT, 09/27/2024 (MT Newswires) -- Aytu BioPharma ( AYTU ) shares slumped 19% pre-bell Friday after the company reported weaker fiscal Q4 financial results. Fenbo Holdings ( FEBO ) shares retreated 17%, erasing Thursday's rally. enVVeno Medical (NVNO) shares fell 16% after pricing a $15 million public offering of common shares and pre-funded warrants. Telesis Bio ( TBIO...
Sanofi, Regeneron Pharmaceuticals Receive Chinese Regulator's Approval for Dupixent as Chronic Obstructive Pulmonary Disease Treatment
Sanofi, Regeneron Pharmaceuticals Receive Chinese Regulator's Approval for Dupixent as Chronic Obstructive Pulmonary Disease Treatment
Oct 2, 2024
07:38 AM EDT, 09/27/2024 (MT Newswires) -- Sanofi ( SNY ) and Regeneron Pharmaceuticals ( REGN ) said Friday that China's National Medical Products Administration has approved Dupixent as an add-on maintenance treatment for adults with uncontrolled chronic obstructive pulmonary disease, or COPD, characterized by raised blood eosinophils. The companies said the approval particularly covers patients who are under treatment...
Analysis-Mining industry struggles with valuation gap amid shift to copper
Analysis-Mining industry struggles with valuation gap amid shift to copper
Oct 2, 2024
LONDON (Reuters) - Leading mining companies are struggling to balance investor expectations for hefty returns with paying the necessary premiums to buy pure play copper companies as global demand for the metal sends valuations soaring. Big diversified miners including Rio Tinto, BHP Group ( BHP ) and Glencore ( GLCNF ), pressured by a slowdown in global economic growth and...
Copyright 2023-2026 - www.financetom.com All Rights Reserved